 Zimbabwe
"Zimbabwe" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A republic in southern Africa, east of ZAMBIA and BOTSWANA and west of MOZAMBIQUE. Its capital is Harare. It was formerly called Rhodesia and Southern Rhodesia.
| Descriptor ID |
D015030
|
| MeSH Number(s) |
Z01.058.290.175.960
|
| Concept/Terms |
Zimbabwe- Zimbabwe
- Zimbabwe Rhodesia
- Southern Rhodesia
- Republic of Zimbabwe
- Rhodesia, Southern
|
Below are MeSH descriptors whose meaning is more general than "Zimbabwe".
Below are MeSH descriptors whose meaning is more specific than "Zimbabwe".
This graph shows the total number of publications written about "Zimbabwe" by people in this website by year, and whether "Zimbabwe" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 | | 2000 | 0 | 1 | 1 | | 2003 | 0 | 1 | 1 | | 2007 | 0 | 2 | 2 | | 2008 | 0 | 1 | 1 | | 2009 | 0 | 1 | 1 | | 2010 | 0 | 2 | 2 | | 2011 | 0 | 3 | 3 | | 2013 | 0 | 1 | 1 | | 2014 | 0 | 4 | 4 | | 2015 | 0 | 1 | 1 | | 2016 | 0 | 1 | 1 | | 2017 | 0 | 3 | 3 | | 2018 | 0 | 3 | 3 | | 2021 | 0 | 1 | 1 | | 2022 | 0 | 3 | 3 | | 2023 | 0 | 3 | 3 | | 2024 | 0 | 2 | 2 | | 2025 | 0 | 6 | 6 | | 2026 | 0 | 5 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Zimbabwe" by people in Profiles.
-
Mazhindu T, Nyangwara VA, Borok MZ, Masimirembwa C, Flaig T, Campbell TB, Ndlovu N. Doxorubicin-induced early-onset chronic progressive cardiotoxicity, pharmacogenetics and survival among breast cancer patients in Zimbabwe. S Afr Med J. 2026 Jun 02; 116(5):e3655.
-
Burkhart Colorado AS, Nusbacher NM, O'Connor J, Marden T, Higgins J, Neff CP, Fiorillo S, Campbell TB, Borok M, Boyd K, Sterrett J, Palmer BE, Lozupone C. The impact of western versus agrarian diet consumption on gut microbiome composition and immune dysfunction in people living with HIV in rural and urban Zimbabwe. Microbiome. 2026 May 12; 14(1).
-
Katena NA, Shamu S, Fana GT, Manasa J, Rusakaniko S. Evaluating the outcomes of a community-based health literacy intervention for hypertension and diabetes in Harare, Zimbabwe: a cluster randomized controlled trial. BMC Prim Care. 2026 04 22; 27(1).
-
Mhlanga FG, Szydlo DW, Mayo AJ, Bunge K, Fairlie L, Nakabiito C, Musara P, Mgodi NM, Dadabhai S, Scheckter R, Anderson PL, Marzinke MA, Chappell C, Gadama LA, Richardson BA, Piper JM, Hillier SL. Safety, acceptability, and adherence to dapivirine vaginal ring and oral pre-exposure prophylaxis for HIV prevention in the second trimester of pregnancy: a multicountry, open-label, phase 3b randomised trial. Lancet HIV. 2026 Mar; 13(3):e176-e184.
-
Borok MZ, Fiorillo S, Manyeruke F, Makoni T, Gudza I, Mutimuri M, Phiri M, Nyagura T, White IE, Rapaport R, Bock A, Nalwoga A, Campbell TW, Campbell TB. Improved screening for pulmonary Kaposi sarcoma in a low-resource setting. AIDS. 2026 Jun 01; 40(6):744-752.
-
Mazhindu TA, Chase ED, Joel M, Ndlovu N, Borok MZ, Masimirembwa C, Hendricks AE. Pharmacogenomic Impact on Breast Cancer Survival for Black Zimbabwean Patients on Tamoxifen. JCO Glob Oncol. 2025 Nov; 11:e2500367.
-
Taruvinga T, Chingono RS, Tembo M, Olaru ID, Masiye K, Madanhire C, Munhenzva S, Sibanda S, Mafuva L, O'Sullivan N, Osman AY, Deane K, Bandason T, Munyanyi M, Makoni AC, Ngwenya S, Webb K, Chinyanga TT, Ferrand RA, Dixon J, Kranzer K, McCoy D. Understanding the impact of the COVID-19 pandemic and its control measures on women and children: a Zimbabwean case study. Front Public Health. 2025; 13:1659703.
-
Parikh UM, Kudrick LD, Levy L, Bosek E, Chohan BH, Mukui I, Masyuko S, Ndlovu N, Mahaka I, Mugurungi O, Ncube G, Hettema A, Matse SN, Mullick S, Wallis CL, Heaps AL, Penrose KJ, McCormick KD, Wiesner L, Anderson PL, Peterson JM, Celum C, Richardson BA, Castor D, Allen S, Torjesen K, Mellors JW. A cross-sectional study evaluating the frequency of HIV drug resistance mutations among individuals diagnosed with HIV-1 in tenofovir disoproxil fumarate-based pre-exposure prophylaxis rollout programmes in Kenya, Zimbabwe, Eswatini and South Africa. J Int AIDS Soc. 2025 Aug; 28(8):e70011.
-
Elbur AI, Donnell D, Hosek S, Dye B, Velloza J, Delany-Moretlwe S, Celum C. The Association Between Use of Adherence Support Interventions and Adherence to HIV Preexposure Prophylaxis Among Young South African and Zimbabwean Women in HPTN 082. AIDS Behav. 2025 Aug; 29(8):2483-2494.
-
Alba C, Malhotra S, Horsfall S, Barnhart ME, Bekker A, Chapman K, Cunningham CK, Fast PE, Fouda GG, Freedberg KA, Goga A, Ghazaryan LR, Leroy V, Mann C, McCluskey MM, McFarland EJ, Muturi-Kioi V, Permar SR, Shapiro R, Sok D, Stranix-Chibanda L, Weinstein MC, Ciaranello AL, Dugdale CM. Cost-effectiveness of broadly neutralizing antibodies for HIV prophylaxis for infants born in settings with high HIV burdens. PLoS One. 2025; 20(3):e0318940.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|